CBT an ‘add-on’ treatment to HRT – updated menopause guidance

7 November 2024

Getty/MStudioImages

By Sarah Lowden

Hormone replacement therapy is still the first treatment recommended for vasomotor symptoms associated with menopause, but cognitive behavioural therapy should be considered as an additional treatment, updated guidelines state.

The National Institute for Health and Care Excellence (NICE) said HRT is the recommended option and advises GPs to tailor information about the benefits and risks based on age, individual circumstances, and any potential risk factors.

NICE points out that while there are some increased risks associated with HRT, it is unlikely to impact overall life expectancy.

The updated guideline adds that CBT should also be discussed with women over 40, and if used in combination with HRT it “may lead to better outcomes”.

'HRT unlikely to impact life expectancy'

NICE said evidence showed the talking therapy was beneficial for women with vasomotor symptoms and is a treatment option to be used alongside HRT, or as an option for patients who prefer not to take HRT or for whom it is not advised.







Log in or join for free to read more

You might also like